Overview
Giuseppe Piscosquito practices in London, United Kingdom. Mr. Piscosquito is highly rated in 4 conditions, according to our data. His top areas of expertise are Charcot-Marie-Tooth Disease, Miller-Fisher Syndrome, Refsum Disease, and Primary Lateral Sclerosis.
His clinical research consists of co-authoring 61 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Charcot-Marie-Tooth DiseaseMr. Piscosquito isDistinguished. Learn about Charcot-Marie-Tooth Disease.
- Advanced
- Miller-Fisher SyndromeMr. Piscosquito isAdvanced. Learn about Miller-Fisher Syndrome.
- Primary Lateral SclerosisMr. Piscosquito isAdvanced. Learn about Primary Lateral Sclerosis.
- Refsum DiseaseMr. Piscosquito isAdvanced. Learn about Refsum Disease.
- Experienced
- ADULT SyndromeMr. Piscosquito isExperienced. Learn about ADULT Syndrome.
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- AnhidrosisMr. Piscosquito isExperienced. Learn about Anhidrosis.
- Brown SyndromeMr. Piscosquito isExperienced. Learn about Brown Syndrome.
- Chronic Inflammatory Demyelinating PolyneuropathyMr. Piscosquito isExperienced. Learn about Chronic Inflammatory Demyelinating Polyneuropathy.
- Chronic PolyradiculoneuritisMr. Piscosquito isExperienced. Learn about Chronic Polyradiculoneuritis.